Auto Amazon Links: No products found. Blocked by captcha.
In a groundbreaking move, the healthcare assessment body for England, Wales, and Northern Ireland is recommending a more personalized approach to treating the millions of people diagnosed with type 2 diabetes. The National Institute for Health and Care Excellence (NICE) suggests a significant shift in diabetes care, including greater access to newer medicines, such as weight-loss drugs, in an effort to prevent complications like heart disease, strokes, and kidney damage.
With approximately 4.6 million people in the UK diagnosed with diabetes, of which 90% have type 2, and an additional 1.3 million likely undiagnosed, the importance of tailored treatment strategies cannot be overstated. NICE is advocating for the use of newer diabetes medications called SGLT-2 inhibitors as the first-line treatment for all diabetes patients. These drugs not only lower blood sugar levels but also protect the heart and kidneys, potentially saving lives and reducing healthcare costs.
The move away from a one-size-fits-all approach towards a more individualized treatment plan is seen as a crucial step in addressing the growing prevalence of type 2 diabetes. However, access to these newer medications is not uniform across the UK, with certain demographics, such as women, older individuals, and black people, less likely to be prescribed SGLT-2 inhibitors. Increasing the uptake of these drugs could lead to significant health improvements across the nation, according to Dr. Waqaar Shah, chair of the guideline committee.
Under the draft guidance issued by NICE, approximately 750,000 more people with type 2 diabetes will be offered GLP-1 agonists like semaglutide and liraglutide, which have gained popularity for their role in weight-loss programs. These drugs, recommended for adults with cardiovascular disease and some who develop type 2 diabetes before the age of 40, can help lower blood sugar levels and support weight loss efforts. The updated guidelines represent a significant evolution in type 2 diabetes treatment, aiming to prevent serious complications before they occur and ultimately improve health outcomes for individuals living with this condition
Read the full article from The BBC here: Read More
Auto Amazon Links: No products found. Blocked by captcha.